Las Vegas NV 2型糖尿病临床试验
18项针对 2型糖尿病的研究正在 Las Vegas及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
招募中2 期
- Excel Clinical Research, LLC, Las Vegas
- Palm Research Center Tenaya, Las Vegas
Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema
招募中3 期
- Palm Research Center Inc-Vegas, Las Vegas
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
招募中3 期
- Las Vegas Clinical Trials, Las Vegas
- AB Clinical Trials, Las Vegas
- Palm Research Center, Las Vegas
- 以及另外 2 项
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
招募中3 期
- Palm Research Center, Las Vegas
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
招募中欢迎健康志愿者
- Southwest Medical Associates- Optum Nevada, Las Vegas
- Vector Clinical Trials, Las Vegas
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
招募中3 期
- Research Site, Las Vegas
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
招募中3 期
- AURORA-2 Clinical Site, Las Vegas
Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
招募中2 期
- DaVita Clinical Research, Las Vegas
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
招募中3 期
- Research Site, Las Vegas
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
招募中2 期
- Alliance Clinical - Las Vegas, Las Vegas
- Palm Research Center, Inc., Las Vegas
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
招募中2 期
- Vector Clinical Trials, Las Vegas
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
招募中3 期
- Palm Research Center Inc, Las Vegas
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
招募中3 期
- Research Site, Las Vegas
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
招募中3 期
- Palm Research Center Inc-Vegas, Las Vegas
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
招募中3 期
- Research Site, Las Vegas
Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus
招募中2 期
- Santa Rosa Medical Centers of Nevada, Las Vegas
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy
招募中2 期
- Excel Clinical Research, Las Vegas
HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes
招募中2 期
- Alliance Clinical Las Vegas (Excel Clinical Research), Las Vegas
其他城市的 2型糖尿病试验
- San Antonio, TX37 项研究
- Houston, TX31 项研究
- Orlando, FL24 项研究
- Boston, MA20 项研究
- Miami, FL19 项研究
- Chicago, IL19 项研究
- Dallas, TX19 项研究
- Columbus, OH18 项研究
- Atlanta, GA17 项研究
- San Diego, CA17 项研究
- Los Angeles, CA16 项研究
- New York City, NY16 项研究
Las Vegas的其他研究
- 肥胖症27 项研究
- 超重23 项研究
- 非小细胞肺癌13 项研究
- 重度抑郁症13 项研究
- 乳腺癌10 项研究
- 阿尔茨海默病8 项研究
- 前列腺癌8 项研究
- 急性髓系白血病8 项研究
- 癌症（所有类型）8 项研究
- 脂肪性肝病7 项研究
- 子宫内膜癌7 项研究
- 抑郁症7 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月5日。每项研究自行设定入选标准，由研究团队决定谁能参与。